FDA approves Indivior’s monthly injection to treat opioid addiction

STAT – A new form of a widely used opioid addiction treatment that is injected monthly instead of taken daily as a tablet was approved Thursday by the Food and Drug Administration. Experts say the eagerly anticipated new version of the drug may help patients reduce relapses, disrupt the treatment market, and possibly dispel misconceptions about the drug’s potential for abuse.

Indivior is the first company to gain approval for a monthly injection of buprenorphine. The company is best known for Suboxone, a daily formulation that combines buprenorphine with naloxone into a film that dissolves under the tongue.

Read more at STAT.

News Image
Suboxone, created by Indivior the same company who was approved for buprenorphine
Topics
Neuroscience
Image Citation

Jr de Barbosa, CC BY-SA 3.0